Aladine A Elsamadicy1,2, Owoicho Adogwa3, David T Lubkin1, Amanda R Sergesketter1, Sohrab Vatsia1, Eric W Sankey1, Joseph Cheng4, Carlos A Bagley5, Isaac O Karikari1. 1. Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA. 2. Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA. 3. Department of Neurosurgery, Rush University Medical Center, Chicago, IL, USA. 4. Department of Neurosurgery, University of Cincinnati, Cincinnati, OH, USA. 5. Department of Neurosurgery, University of Texas Southwestern, Dallas TX, USA.
Abstract
BACKGROUND: This study aims to assess 30-day complication and unplanned readmission rates associated with resection of metastatic spinal tumors. METHODS: Medical records were reviewed for 135 adults who underwent elective resection of a spinal cord tumor. Patient demographics, comorbidities, and tumor characteristics were collected. Tumor pathology was analyzed and diagnosed by a pathologist. The primary outcomes were intra- and 30-day post-operative complication and readmission rates. RESULTS: Of the 135 spinal tumor resections, 30 (22.2%) cases were metastatic. The most common tumor pathology was bone (13.3%) and the most common locations were thoracic (45.2%), and cervical (32.7%). Most patients had an open surgery (96.7%), with a mean laminectomy/laminoplasty level of 1.9±1.5 and mean operative time of 328.4±658.0 min. There was a 3.3% incidence rate of intraoperative durotomies, with no spinal cord or nerve root injuries. Post-operatively, 44.8% of patients were transferred to the intensive care unit (ICU). The most common post-operative complications were weakness (20.0%), new sensory deficits (16.7%), and hypotension (13.3%). The mean length of stay was 8.8±7.6 days, with the majority of patients discharged home (96.7%). The 30-day readmission rate was 9.7%, with the most common 30-day complications being uncontrolled pain (16.7%), sensory-motor deficits (13.3%), and fever (10.0%). CONCLUSIONS: Our study suggests that weakness, sensory deficits, and uncontrolled pain are the most common complications after resection of spinal metastases, with a relatively high associated 30-day readmission rate. Further studies are necessary to corroborate our findings and identify strategies to reduce complication and readmission rates after resection of spinal metastases.
BACKGROUND: This study aims to assess 30-day complication and unplanned readmission rates associated with resection of metastatic spinal tumors. METHODS: Medical records were reviewed for 135 adults who underwent elective resection of a spinal cord tumor. Patient demographics, comorbidities, and tumor characteristics were collected. Tumor pathology was analyzed and diagnosed by a pathologist. The primary outcomes were intra- and 30-day post-operative complication and readmission rates. RESULTS: Of the 135 spinal tumor resections, 30 (22.2%) cases were metastatic. The most common tumor pathology was bone (13.3%) and the most common locations were thoracic (45.2%), and cervical (32.7%). Most patients had an open surgery (96.7%), with a mean laminectomy/laminoplasty level of 1.9±1.5 and mean operative time of 328.4±658.0 min. There was a 3.3% incidence rate of intraoperative durotomies, with no spinal cord or nerve root injuries. Post-operatively, 44.8% of patients were transferred to the intensive care unit (ICU). The most common post-operative complications were weakness (20.0%), new sensory deficits (16.7%), and hypotension (13.3%). The mean length of stay was 8.8±7.6 days, with the majority of patients discharged home (96.7%). The 30-day readmission rate was 9.7%, with the most common 30-day complications being uncontrolled pain (16.7%), sensory-motor deficits (13.3%), and fever (10.0%). CONCLUSIONS: Our study suggests that weakness, sensory deficits, and uncontrolled pain are the most common complications after resection of spinal metastases, with a relatively high associated 30-day readmission rate. Further studies are necessary to corroborate our findings and identify strategies to reduce complication and readmission rates after resection of spinal metastases.
Authors: Timothy C Ryken; Kurt M Eichholz; Peter C Gerszten; William C Welch; Ziya L Gokaslan; Daniel K Resnick Journal: Neurosurg Focus Date: 2003-11-15 Impact factor: 4.047
Authors: Darryl Lau; Andrew K Chan; Alexander A Theologis; Dean Chou; Praveen V Mummaneni; Shane Burch; Sigurd Berven; Vedat Deviren; Christopher Ames Journal: J Neurosurg Spine Date: 2016-04-29
Authors: Marcelo Gruenberg; Maximiliano E Mereles; Gastón O Camino Willhuber; Marcelo Valacco; Matias G Petracchi; Carlos A Solá Journal: Global Spine J Date: 2017-04-11
Authors: Jie Jane Chen; Adam J Sullivan; Diana D Shi; Monica S Krishnan; Lauren M Hertan; Claudia S Roldan; Mai Anh Huynh; Alexander Spektor; M Mohsin Fareed; Tai Chung Lam; Tracy A Balboni Journal: Adv Radiat Oncol Date: 2021-02-07
Authors: Aladine A Elsamadicy; Andrew B Koo; Wyatt B David; Cheryl K Zogg; Adam J Kundishora; Christopher S Hong; Gregory A Kuzmik; Ramana Gorrepati; Pedro O Coutinho; Luis Kolb; Maxwell Laurans; Khalid Abbed Journal: Spine (Phila Pa 1976) Date: 2021-06-15 Impact factor: 3.241